Cargando…
The Additive Values of the Classification of Higher Serum Uric Acid Levels as a Diagnostic Criteria for Metabolic-Associated Fatty Liver Disease
Serum uric acid (SUA) is regarded as an independent risk factor for nonalcoholic fatty liver disease (NAFLD). However, the role of SUA in the new diagnosis flowchart of metabolic-associated fatty liver disease (MAFLD) remains unclear. A cross-sectional study enrolled consecutive individuals with ult...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460100/ https://www.ncbi.nlm.nih.gov/pubmed/36079844 http://dx.doi.org/10.3390/nu14173587 |
_version_ | 1784786663724023808 |
---|---|
author | He, Jie Ye, Junzhao Sun, Yanhong Feng, Shiting Chen, Youpeng Zhong, Bihui |
author_facet | He, Jie Ye, Junzhao Sun, Yanhong Feng, Shiting Chen, Youpeng Zhong, Bihui |
author_sort | He, Jie |
collection | PubMed |
description | Serum uric acid (SUA) is regarded as an independent risk factor for nonalcoholic fatty liver disease (NAFLD). However, the role of SUA in the new diagnosis flowchart of metabolic-associated fatty liver disease (MAFLD) remains unclear. A cross-sectional study enrolled consecutive individuals with ultrasonography and magnetic resonance imaging–based proton density fat fraction (MRI-PDFF) measurements in the First Affiliated Hospital of Sun Yat-sen University from January 2015 to December 2021. All patients were divided into four groups according to their baseline SUA levels and sex. Of the 3537 ultrasound-diagnosed and 1017 MRI-PDFF-diagnosed MAFLD patients included, the prevalence of severe steatosis determined with ultrasound or MRI-PDFF increased across the serum SUA quartiles. The SUA cutoffs were identified as ≥478 µmol/L and ≥423.5 µmol/L for severe steatosis in male and female MAFLD, respectively. Furthermore, using these cutoff values, patients with higher SUA levels in the NAFLD–non-MAFLD group had higher liver fat contents than those without (16.0% vs. 9.7%, p < 0.001). The lean/normal-weight NAFLD–non-MAFLD patients with higher SUA levels are still at high risk of severe steatosis. This study supports the rationale for SUA being established as another risk factor for metabolic dysfunctions in lean/normal-weight MAFLD. |
format | Online Article Text |
id | pubmed-9460100 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94601002022-09-10 The Additive Values of the Classification of Higher Serum Uric Acid Levels as a Diagnostic Criteria for Metabolic-Associated Fatty Liver Disease He, Jie Ye, Junzhao Sun, Yanhong Feng, Shiting Chen, Youpeng Zhong, Bihui Nutrients Article Serum uric acid (SUA) is regarded as an independent risk factor for nonalcoholic fatty liver disease (NAFLD). However, the role of SUA in the new diagnosis flowchart of metabolic-associated fatty liver disease (MAFLD) remains unclear. A cross-sectional study enrolled consecutive individuals with ultrasonography and magnetic resonance imaging–based proton density fat fraction (MRI-PDFF) measurements in the First Affiliated Hospital of Sun Yat-sen University from January 2015 to December 2021. All patients were divided into four groups according to their baseline SUA levels and sex. Of the 3537 ultrasound-diagnosed and 1017 MRI-PDFF-diagnosed MAFLD patients included, the prevalence of severe steatosis determined with ultrasound or MRI-PDFF increased across the serum SUA quartiles. The SUA cutoffs were identified as ≥478 µmol/L and ≥423.5 µmol/L for severe steatosis in male and female MAFLD, respectively. Furthermore, using these cutoff values, patients with higher SUA levels in the NAFLD–non-MAFLD group had higher liver fat contents than those without (16.0% vs. 9.7%, p < 0.001). The lean/normal-weight NAFLD–non-MAFLD patients with higher SUA levels are still at high risk of severe steatosis. This study supports the rationale for SUA being established as another risk factor for metabolic dysfunctions in lean/normal-weight MAFLD. MDPI 2022-08-31 /pmc/articles/PMC9460100/ /pubmed/36079844 http://dx.doi.org/10.3390/nu14173587 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article He, Jie Ye, Junzhao Sun, Yanhong Feng, Shiting Chen, Youpeng Zhong, Bihui The Additive Values of the Classification of Higher Serum Uric Acid Levels as a Diagnostic Criteria for Metabolic-Associated Fatty Liver Disease |
title | The Additive Values of the Classification of Higher Serum Uric Acid Levels as a Diagnostic Criteria for Metabolic-Associated Fatty Liver Disease |
title_full | The Additive Values of the Classification of Higher Serum Uric Acid Levels as a Diagnostic Criteria for Metabolic-Associated Fatty Liver Disease |
title_fullStr | The Additive Values of the Classification of Higher Serum Uric Acid Levels as a Diagnostic Criteria for Metabolic-Associated Fatty Liver Disease |
title_full_unstemmed | The Additive Values of the Classification of Higher Serum Uric Acid Levels as a Diagnostic Criteria for Metabolic-Associated Fatty Liver Disease |
title_short | The Additive Values of the Classification of Higher Serum Uric Acid Levels as a Diagnostic Criteria for Metabolic-Associated Fatty Liver Disease |
title_sort | additive values of the classification of higher serum uric acid levels as a diagnostic criteria for metabolic-associated fatty liver disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460100/ https://www.ncbi.nlm.nih.gov/pubmed/36079844 http://dx.doi.org/10.3390/nu14173587 |
work_keys_str_mv | AT hejie theadditivevaluesoftheclassificationofhigherserumuricacidlevelsasadiagnosticcriteriaformetabolicassociatedfattyliverdisease AT yejunzhao theadditivevaluesoftheclassificationofhigherserumuricacidlevelsasadiagnosticcriteriaformetabolicassociatedfattyliverdisease AT sunyanhong theadditivevaluesoftheclassificationofhigherserumuricacidlevelsasadiagnosticcriteriaformetabolicassociatedfattyliverdisease AT fengshiting theadditivevaluesoftheclassificationofhigherserumuricacidlevelsasadiagnosticcriteriaformetabolicassociatedfattyliverdisease AT chenyoupeng theadditivevaluesoftheclassificationofhigherserumuricacidlevelsasadiagnosticcriteriaformetabolicassociatedfattyliverdisease AT zhongbihui theadditivevaluesoftheclassificationofhigherserumuricacidlevelsasadiagnosticcriteriaformetabolicassociatedfattyliverdisease AT hejie additivevaluesoftheclassificationofhigherserumuricacidlevelsasadiagnosticcriteriaformetabolicassociatedfattyliverdisease AT yejunzhao additivevaluesoftheclassificationofhigherserumuricacidlevelsasadiagnosticcriteriaformetabolicassociatedfattyliverdisease AT sunyanhong additivevaluesoftheclassificationofhigherserumuricacidlevelsasadiagnosticcriteriaformetabolicassociatedfattyliverdisease AT fengshiting additivevaluesoftheclassificationofhigherserumuricacidlevelsasadiagnosticcriteriaformetabolicassociatedfattyliverdisease AT chenyoupeng additivevaluesoftheclassificationofhigherserumuricacidlevelsasadiagnosticcriteriaformetabolicassociatedfattyliverdisease AT zhongbihui additivevaluesoftheclassificationofhigherserumuricacidlevelsasadiagnosticcriteriaformetabolicassociatedfattyliverdisease |